A 'mild' COVID-19 case just means you don't end up in the hospital, epidemiologists caution
There was good news and bad news about COVID-19 and its Omicron variant on Tuesday.
U.S. health officials said the new variant is spreading fast and will soon become the dominant coronavirus strain in the U.S., demoting Delta, but Pfizer announced that its new antiviral drug Paxlovid has proved extremely effective at keeping high-risk COVID-19 patients alive and out of the hospital, and appears to work against the Omicron variant. A South African study found that two doses of Pfizer's vaccine was only 33 percent effective against Omicron infection and 70 percent effective at preventing hospitalization and death, but also that the illness from this new variant appears more mild than with previous strains.
Even if Omicron proves to be more mild, "'mild' doesn't mean 'no big deal,'" Joanne Kenen cautions in Politico's Nightly newsletter. "Mild Covid-19 can still cause a whole lot of illness, a whole lot of economic disruption, a whole lot of strain on health care systems around the world." For one thing, if the new variant were 75 percent less deadly than previous strains but infected four times as many people, "the same number of lives would be lost," she notes. And for people who recover, nobody knows about Omicron and lingering long-COVID symptoms.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Also, "'mild' to an epidemiologist doesn't mean the same thing that 'mild' indicates to you and me," Kenen adds. "Mild to us means not feeling so bad. Mild to the public health professional just means you aren't in the hospital."
A virus "can knock you off your feet and debilitate you for a few days and we'd still call it mild," said Marcus Plescia, chief medical officer at the American Society of State and Territorial Health Officials. "Mild" covers everything from the sniffles to being bedridden with fever and aches, adds Megan Ranney, an emergency physician at Brown University. "Even if I don't get super-sick, thanks to the vaccines," she told Nightly, "I can't afford to take 10 days off of work." Read more at Politico.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
France's 'reckoning' over largest-ever child sex abuse trial
The Explainer Joël Le Scouarnec case is latest in a series of high-profile scandals to have prompted 'deep soul searching'
By The Week Staff Published
-
Crossword: March 4, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: March 4, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published